NDC Active Ingredient Belimumab

Active Ingredient Information

What is the usage for Belimumab?

This medication is used to treat a certain type of lupus, systemic lupus erythematosus, in patients who are receiving other lupus medicines. It works by binding to a protein (found in high levels in patients with active lupus) in the blood and limiting the activity of the protein. It helps decrease the symptoms of lupus. Belimumab is a type of medication called a monoclonal antibody.

How many products in the NDC database contain Belimumab?

The NDC database has 3 products with the active ingredient Belimumab. The following table lists all the products that have this active ingredient.

NDC Products with Belimumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
49401-088Proprietary Name: Benlysta BelimumabSolutionSubcutaneousGlaxosmithkline LlcACTIVE
49401-101Proprietary Name: Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcACTIVE
49401-102Proprietary Name: Benlysta BelimumabInjection, Powder, Lyophilized, For SolutionIntravenousGlaxosmithkline LlcACTIVE
<